Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Brigit Biofarmaka Teknologi TbkISX:OBAT -0.82% Receivables Turnover is 0.00 as of . 20. The stock has 1 warning sign investors should review. Among 1,946 Consumer Packaged Goods companies, PT Brigit Biofarmaka Teknologi Tbk ranks worse than 51387.41% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. PT Brigit Biofarmaka Teknologi Tbk's Revenue for the
six
months ended in . 20 was Rp0.00 Mil. PT Brigit Biofarmaka Teknologi Tbk's average Accounts Receivable for the
six
months ended in . 20 was Rp0.00 Mil.
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
PT Brigit Biofarmaka Teknologi Tbk Receivables Turnover Related Terms
PT Brigit Biofarmaka Teknologi Tbk Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Brigit Biofarmaka Teknologi Tbk Receivables Turnover Chart
PT Brigit Biofarmaka Teknologi Tbk Annual Data
Trend
Receivables Turnover
PT Brigit Biofarmaka Teknologi Tbk Semi-Annual Data
Receivables Turnover
ISX:OBAT vs KHC, GIS: Receivables Turnover Comparison
For the Packaged Foods subindustry, PT Brigit Biofarmaka Teknologi Tbk's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Brigit Biofarmaka Teknologi Tbk Receivables Turnover vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, PT Brigit Biofarmaka Teknologi Tbk's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where PT Brigit Biofarmaka Teknologi Tbk's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) has a Receivables Turnover of 0.00 as of . 20. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on PT Brigit Biofarmaka Teknologi Tbk and its competitors. According to the industry distribution chart, PT Brigit Biofarmaka Teknologi Tbk ranks #999999 out of 1946 companies in the Consumer Packaged Goods industry.
Is PT Brigit Biofarmaka Teknologi Tbk's Receivables Turnover too high?
PT Brigit Biofarmaka Teknologi Tbk's current Receivables Turnover is 0.00. Based on the distribution chart, PT Brigit Biofarmaka Teknologi Tbk ranks #999999 out of 1946 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does PT Brigit Biofarmaka Teknologi Tbk's Receivables Turnover compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, PT Brigit Biofarmaka Teknologi Tbk ranks #999999 out of 1946 companies for Receivables Turnover. This places PT Brigit Biofarmaka Teknologi Tbk in the lower half of its industry. The industry median Receivables Turnover is 9.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Consumer Packaged Goods company?
The median Receivables Turnover among Consumer Packaged Goods companies is 9.38, based on 1,946 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on PT Brigit Biofarmaka Teknologi Tbk and its competitors. For the Consumer Packaged Goods industry, the median Receivables Turnover is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Brigit Biofarmaka Teknologi Tbk's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Brigit Biofarmaka Teknologi Tbk stock overvalued right now?
PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For PT Brigit Biofarmaka Teknologi Tbk (ISX:OBAT), the current Receivables Turnover is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Brigit Biofarmaka Teknologi Tbk is engaged in the herbal, cosmetic, and functional and botanical beverage manufacturing industry. The herbal products are used for traditional medicine products, including herbal capsules and honey, while the cosmetic products are various products for decorative and skin care. The functional and botanical beverage products are used for powdered drinks and tea.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:OBAT has been successfully added to your 
